Company Filing History:
Years Active: 1998-2006
Title: The Innovative Contributions of Jose Mordoh
Introduction
Jose Mordoh is a prominent inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 2 patents, his work focuses on developing methods and compositions that target tumor cells and improve cancer treatment.
Latest Patents
Mordoh's latest patents include groundbreaking inventions that address critical challenges in tumor therapy. One of his notable patents is titled "Compositions and methods for tumour therapy." This invention describes compositions and methods that decrease or inhibit osteonectin activity in tumor cells, including cancer cells. The result is that the cells cease to be tumor-like or become less tumor-like. Additionally, pharmaceutical compositions and therapies based on this invention are also described.
Another significant patent is "Monoclonal antibodies reactive with tumor proliferating cells." This invention concerns monoclonal antibodies directed against breast carcinoma cells. The process involves producing immunoglobulin-secreting hybridoma cultures using undifferentiated breast cancer cells as antigens for immunization. Hybridomas that secrete antibodies highly reactive with tumor proliferating cells are selected. These monoclonal antibodies have particular applications in aiding the diagnosis or treatment of cancer.
Career Highlights
Throughout his career, Jose Mordoh has worked with various institutions, including the Fundación Instituto Leloir. His research has significantly impacted the understanding and treatment of cancer, showcasing his dedication to advancing medical science.
Collaborations
Mordoh has collaborated with notable colleagues, including Alicia Ines Bravo and Silvia Leis De Cerone. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
Jose Mordoh's innovative contributions to cancer therapy through his patents highlight his commitment to improving treatment options for patients. His work continues to inspire advancements in the field of oncology.